Budapest, Hungary

Peter Aranyi

USPTO Granted Patents = 16 

Average Co-Inventor Count = 12.0

ph-index = 4

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 1984-2011

Loading Chart...
16 patents (USPTO):Explore Patents

Title: Peter Aranyi: A Budapest-based Inventor with Remarkable Patents

Introduction:

Meet Peter Aranyi, an exceptional inventor hailing from Budapest, Hungary. With an impressive portfolio of 16 patents and a passion for innovation, Aranyi has made significant contributions to the fields of molecular research and enzyme inhibition. Let's delve into his latest patents, explore his notable career highlights, and shed light on his collaborative ventures.

Latest Patents:

Aranyi's recent inventions demonstrate his expertise in medicinal chemistry and the development of new compounds. Two noteworthy patents include:

1. Aminoquinoline Derivatives and their use as Adenosine A3 Ligands:

This patent highlights Aranyi's work on an adenosine A3 receptor ligand, represented by the general formula (I). These derivatives offer potential applications in the treatment of various medical conditions related to the adenosine receptor.

2. Fluoropyrrolidines having Dipeptidyl Peptidase Enzyme Inhibitory Activity:

Aranyi's patent covers the discovery of fluoro-containing compounds, serving as potent inhibitors of the DPP-IV enzyme. These compounds, represented by formula (I), possess valuable therapeutic potential in the management of diabetes and related metabolic disorders.

Career Highlights:

Peter Aranyi's career boasts remarkable achievements in collaboration with renowned pharmaceutical companies. Here are some highlights:

1. Sanofi-Aventis:

Aranyi's association with Sanofi-Aventis, a global pharmaceutical giant, has fostered groundbreaking advancements in drug discovery and development. His contributions in medicinal chemistry have significantly impacted the company's research pipelines.

2. Richter Gedeon Vegyeszeti Gyar Rt:

Aranyi's affiliation with Richter Gedeon, a leading Hungarian pharmaceutical company, has demonstrated his diverse expertise in the local industry. His innovative contributions have expanded Richter Gedeon's capabilities in drug discovery and development.

Collaborations:

Aranyi's collaborations with skilled researchers and scientists have played a crucial role in his groundbreaking inventions. Two notable collaborators are:

1. Sandor Batori:

Working alongside Sandor Batori, a seasoned researcher, Aranyi has explored novel approaches to drug design and synthesis. Their combined expertise has resulted in several successful projects in the field of medicinal chemistry.

2. Zoltan Kapui:

Aranyi's collaboration with Zoltan Kapui has contributed to advancements in molecular research. Their shared insights and expertise have fueled innovation in drug discovery, particularly in the area of enzyme inhibition.

Conclusion:

Peter Aranyi, a renowned Hungarian inventor, has left an indelible mark in the realms of medicinal chemistry and pharmaceutical research. With an impressive patent portfolio and fruitful collaborations, he continues to push the boundaries of innovation and contribute to the development of next-generation therapies. Aranyi's dedication serves as an inspiration for aspiring inventors and highlights the significance of advancements in patentable inventions.

Note: This article is a fictional representation based on the information provided.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…